Kwality Pharmaceuticals Hits 52-Week High and Receives 'Buy' Call from MarketsMOJO
Kwality Pharmaceuticals, a microcap company in the pharma industry, has been making waves in the stock market with its recent performance. On August 23, 2024, the company's stock price reached a 52-week high of Rs.730.05, outperforming the sector by 4.7%. With a remarkable growth of 91.70% in the past year, Kwality Pharma is a promising player in the market.
Kwality Pharmaceuticals, a microcap company in the pharma industry, has been making waves in the stock market with its recent performance. On August 23, 2024, the company's stock price reached a 52-week high, hitting Rs.730.05. This has caught the attention of investors and analysts, with MarketsMOJO giving a 'Buy' call for the stock.
The stock has been performing exceptionally well, outperforming the sector by 4.7% on the same day. It also touched an intraday high of Rs.730.05, showing a 5.19% increase. This positive trend is further supported by the fact that Kwality Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In terms of overall performance, Kwality Pharmaceuticals has shown a remarkable growth of 91.70% in the past year, while the Sensex has only seen a 23.88% increase. This highlights the company's strong potential and ability to outperform the market.
Kwality Pharmaceuticals is a promising player in the pharma industry, with its consistent growth and positive market sentiment. With its recent 52-week high and 'Buy' call from MarketsMOJO, the company is definitely one to watch out for in the stock market. Investors can expect to see continued success from Kwality Pharmaceuticals in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
